Related Experiment Video
Updated: May 20, 2026

02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Future trends in research in psoriatic arthritis
1Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. dafna.gladman@utoronto.ca
The Journal of Rheumatology. Supplement
|July 4, 2012
Summary
Psoriatic arthritis (PsA) research advances focus on refining disease definitions and identifying biomarkers for early diagnosis and progression. Future work aims to develop novel therapies for PsA.
Area of Science:
- Rheumatology and Immunology
- Inflammatory and Autoimmune Diseases
Background:
- Significant progress has been made in understanding psoriatic arthritis (PsA) over recent decades.
- Current research builds upon these advances, exploring diverse areas of study.
Purpose of the Study:
- To outline future research directions in psoriatic arthritis (PsA).
- To emphasize the need for refined disease definitions, including axial, peripheral, and arthritis mutilans patterns.
- To highlight the importance of identifying biomarkers for early diagnosis, disease expression, progression, and comorbidities.
Main Methods:
- Literature review and synthesis of current research trends in PsA.
- Analysis of the necessity for precise diagnostic criteria.
- Exploration of potential avenues for biomarker discovery.
Main Results:
- Future PsA research will focus on precise disease classification.
- Identification of genetic and other biomarkers is crucial for early detection and management.
- Development of new therapeutic strategies is anticipated.
Conclusions:
- Refined definitions and early diagnosis are key for advancing PsA research.
- Biomarker discovery will drive personalized medicine approaches in PsA.
- Continued research is essential for developing innovative treatments for psoriatic arthritis.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.